What is the “state of the union” for companies seeking growth capital? Are the public markets open for business? What role will credit markets play? In a slowing, inflationary market, what funding models are available to companies looking to unlock growth? Join an expert panel of health care investors, bankers and market-leading strategic acquirers as they dive into the available funding strategies for high growth medical device technologies, with a focus on the following topics:
• What is the “state of the union” for companies raising capital in today’s market, and as you look ahead to 2023, should companies be preparing for a tropical storm or a Category 5 hurricane?
• Will the public markets be “open” for companies as we close out 2022 and look ahead to 2023? What is the profile of a successful IPO candidate in regard to revenue, profitability, growth rate and market dynamic? Are SPACs dead?
• Given the market dynamics of today, what will be the role of the credit markets as a funding source? Any lessons from 2008-2010 to discuss?
• What creative financing relationships are available from strategic acquirers that allow for high growth medical device companies to focus on growth and execution? How is your organization thinking about investing in future growth over the year ahead?